Back to search

Article

Omeprazole and cardiovascular risk via induction of statin dysmetabolism

2024-10-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Statins are a first line treatment for reducing cardiovascular risk. While drug-drug interactions which cause symptomatic side effects are well known, drug- drug interactions which decrease statin effectiveness are poorly understood. <h4>Methods</h4> A multicentre prospective observational study of 1362 participants on chronic statin medication underwent quantitative mass spec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4d4a2948-375b-506f-a774-cad0978d2409
DOI
10.1101/2024.10.14.24315493
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Omeprazole and cardiovascular risk via induction of statin dysmetabolismDOI 10.1101/2024.10.14.24315493
Select a neighboring publication to make it the new centre.